Renal arterial fibromuscular dysplasia (FMD) is a significant cause of renovascular hypertension, especially in younger females. Tobacco constituents have been shown to stimulate proliferation and synthetic activity of cultured human vascular smooth muscle cells. We examined the relationship between smoking and severity of FMD in a group of 50 subjects with the multifocal form of renal arterial FMD. A detailed smoking history was obtained by interview, clinical data at diagnosis of FMD were obtained from medical records, and angiograms were reviewed. Clinical and angiographic features were compared between smokers and non-smokers. Twenty-four sub-
Introduction
Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory vascular disease of unknown aetiology. While many different arteries may be involved, the renal and internal carotid arteries are the most common sites of clinical disease. 1 Stenotic lesions or arterial dissection may produce organ ischaemia, most commonly presenting as renovascular hypertension. 1 Medial fibroplasia accounts for 60-75% of reported cases of renal arterial FMD and typically produces the angiographic multifocal ('string of beads') pattern. 1, 2 Renal arterial medial fibroplasia is predominantly recognised in females of reproductive age. Bilateral renal arterial involvement is common, and unilateral disease most commonly affects the right renal artery. 1, 3 Cigarette smoking is recognised as a risk factor for atherosclerotic vascular disease. Several studies have suggested that smoking is also a risk factor for renal arterial FMD. [4] [5] [6] Tobacco constituents have been shown to stimulate vascular smooth muscle cell (VSMC) proliferation and synthetic activity, [7] [8] [9] which may contribute to the development of FMD.
Correspondence: Professor Richard D Gordon, University Department of Medicine, Greenslopes Private Hospital, Newdegate Street, Brisbane Q4120, Australia Received 9 February 1999; revised and accepted 30 April 1999 jects were smokers. At the time of diagnosis of FMD, smokers were of younger mean age than non-smokers (38.7 years vs 48.9 years, P Ͻ 0.01), had a shorter median history of hypertension (1.5 years vs 8.5 years, P Ͻ 0.05), and had a higher prevalence of unilateral renal atrophy (67% vs 27%, P Ͻ 0.01). The distribution of age at diagnosis of FMD was unimodal in non-smokers and bimodal, with a discrete group of younger subjects, in smokers. We conclude that cigarette smoking is associated with an earlier onset and increased severity of disease in a susceptible subgroup of patients predisposed to multifocal renal arterial FMD.
In this study we sought evidence of a pathogenic role for cigarette smoking in FMD by examining the relationship of cigarette smoking to age at diagnosis and severity of FMD in a group of 50 patients with angiographically proven multifocal renal arterial FMD.
Materials and methods
Sixty-nine hypertensive patients referred to a hypertension unit between 1970 and 1997 were diagnosed as having multifocal renal arterial FMD. Nineteen patients were excluded, including five who were deceased, three who were lost to follow-up, and 11 whose original angiograms were unavailable for analysis. This left 50 patients with angiographicallydiagnosed multifocal renal arterial FMD in the present study.
All subjects were interviewed by one of the authors (AB). Smokers were defined at those who had ever smoked more than one cigarette daily for longer than 1 month. Smoking history was quantified as the number of pack years of smoking prior to the diagnosis of FMD. Duration of hypertension was determined as the number of years between the first diagnosis of sustained hypertension and the diagnosis of FMD.
All angiograms were reviewed by three of the authors (AB, CH, ND). The angiographic appearance of each FMD-affected renal artery was classified as unifocal (focal or tubular) or multifocal. A focal lesion was defined as a solitary stenosis of less than 1 cm in length, and a tubular lesion as a smooth, concentric stenosis of greater than 1 cm in length. A multifocal lesion was defined as two or more adjacent stenoses (multiple in the majority) giving the characteristic 'beaded' appearance. Lesions were classified as unilateral (right or left) or bilateral. 'Unilateral renal atrophy' was defined as a difference in bipolar length of greater than 2 cm between the two kidneys on renal angiography. Renal artery atherosclerosis was defined as a stenosis occurring at the origin or early proximal portion of the main renal artery, and having an appearance characteristic of an atherosclerotic plaque.
Statistical analysis was performed using Statistica software (Release 5.0, StatSoft, Inc, Tulsa, USA). Parametric data are expressed as mean ± standard deviation, and non-parametric as median (range). The t-test for independent samples was used for parametric data, the Mann-Whitney U test for nonparametric data, and the Fisher exact test for dichotomous data. A two-sided probability value of less than 0.05 was considered significant.
Results
The study group consisted of 47 females and three males (Table 1) , and included two familial occurrences (sisters aged 44 and 57, and a niece and aunt aged 42 and 46). Appearances were mixed in six subjects with bilateral FMD, with a multifocal lesion on one side and a unifocal lesion on the other. Twenty-four subjects (two males) were smokers and 26 (one male) non-smokers. Smokers had a median history of smoking of 12 pack years (range 0.3 years to 70 years). Smokers were significantly younger (38.7 ± 14.8 years) at diagnosis of FMD than nonsmokers (48.9 ± 10.7 years, P Ͻ 0.01). The distribution of age at diagnosis also differed between groups ( Figure 1 ). Smokers showed a bimodal distribution with 10 subjects diagnosed between the ages of 15 and 35 years, and 13 subjects between the ages of 40 and 60 years. Non-smokers had a unimodal distribution, with only two younger than 40 years at diagnosis. Smokers had a significantly higher prevalence of unilateral renal atrophy at diagnosis (16 of 24, 67%) than non-smokers (seven of 26, 27%, P Ͻ 0.01). In all cases, the atrophied kidney was ipsilateral to the more severely affected renal artery. Smokers had a significantly shorter history of hypertension (median 1.5 years, range 0-23 years) than nonsmokers (median 8.5 years, range 0-35 years, P Ͻ 0.05). There were no significant differences between smokers and non-smokers with respect to the prevalence of bilateral FMD, blood pressure levels at diagnosis or number of antihypertensives used at diagnosis (Table 1) . However, there was a trend towards a higher prevalence of bilateral FMD in the nonsmokers compared to the smokers (77% vs 50%, P = 0.08). Each of the 'familial' cases was a non-smoker. Six patients had coexistent renal artery atherosclerosis. Four were smokers, aged 48 to 57 years at diagnosis of FMD, and two, aged 62 and 66 years, were non-smokers. Two of these, both smokers, had unilateral renal atrophy at diagnosis. Following exclusion of these six subjects, the differences in age at diagnosis of FMD, history of hypertension, and prevalence of unilateral renal atrophy at diagnosis remained significant (respectively, P Ͻ 0.002, P Ͻ 0.01 and P Ͻ 0.02).
Discussion
In the last 40 years, FMD has become increasingly recognised as a significant cause of renovascular hypertension, particularly in females. 1 Its aetiology, however, remains elusive.
In each of three reports involving 18, 21 and 33 subjects with FMD, a higher prevalence of smoking was noted among patients with FMD compared to controls. [4] [5] [6] As a result, the question of smoking contributing to, and possibly causing FMD was raised. [4] [5] [6] Mackay et al 4 found 13 (72%) of 18 FMD patients to be current smokers, a rate significantly higher than in randomly-drawn sex-and age-matched hypertensive outpatient controls (39% of 18, P Ͻ 0.05). Nicholson et al 5 found a significantly higher percentage of smokers in female FMD patients (71% of 21) than in female controls (41% of 158, P Ͻ 0.0005). Sang et al, 6 in a case-control study of 33 FMD patients (15 with beaded lesions) and 61 renal transplant donor controls, found not only a significantly higher percentage of smokers in the FMD group (79% vs 53%, P = 0.003) but also a positive relationship between pack years of smoking and the presence of FMD (P Ͻ 0.001).
In the current study of 50 subjects with multifocal renal arterial FMD, smokers presented (1) at an earlier age, (2) with a shorter duration of hypertension, and (3) had a significantly higher prevalence of unilateral renal atrophy than non-smokers. These features suggest that the disease was more rapidly progressive and, hence, more severe in smokers.
The age distribution, gender distribution and laterality of disease of our patient population were similar to previous reports. 1, [3] [4] [5] [6] 10 Since the age distribution at diagnosis was unimodal in non-smokers, but bimodal in smokers, smoking may affect a subset of patients with FMD who are 'susceptible', the remainder presenting at a similar age to non-smokers.
This study found a lower prevalence of smoking in FMD patients than previous studies (approx 50% vs 70-80% in other studies [4] [5] [6] ), possibly as a result of effective anti-smoking campaigns by the National Heart Foundation of Australia. The fact that over half the patients with multifocal lesions had never smoked proves conclusively that a personal history of smoking is not essential for the development of FMD. Furthermore, the four patients with a family history of FMD had never smoked, suggesting that whatever genetic factors were operating could achieve phenotypic expression independent of personal smoking. These four patients all had bilateral FMD. Perhaps there is a genetic factor influencing bilaterality versus unilaterality which would complicate analysis of any relationship between smoking and laterality. This may in part explain the trend towards a higher prevalence of bilateral FMD in the non-smokers. For example, a genetic factor might predispose to bilaterality while an environmental factor, namely smoking, predisposes to rapidity of progression and more severe disease.
Smoking may be related to FMD in several ways. The endothelium plays a central role in the control of vascular tone.
11 Impaired endothelium-dependent arterial dilatation has been demonstrated in both active smoking 12, 13 and in prolonged exposure to environmental tobacco smoke.
14 Endothelial dysfunction has been implicated in the pathogenesis of coronary arterial spasm in atherosclerosis. 11 While it has been suggested that cigarette-smoking may induce vascular spasm which, when superimposed on a stenosis due to FMD, may produce a physiologically significant stenosis and renovascular hypertension, 5 this would seem unlikely as any spasm induced by cigarette smoking would be expected to be self-limited and intermittent.
The microaneurysms of medial fibroplasia are characterised by fragmentation or absence of the internal elastic lamina (IEL) with thinning of the underlying media. 2 Elastin damage and enlargement of IEL fenestrae may underlie their pathogenesis. Cigarette smoke may cause damage to elastin and the arterial IEL by inactivation of ␣ 1 -antitrypsin and increased elastase activity 15 or by the upregulation of metalloproteinase production by VSMC. 7 Both nicotine and cotinine stimulate production and secretion of bFGF (a major mitogen for VSMC) by cultured human VSMC, 7 and stimulate DNA synthesis and mitogenesis of cultured human VSMC. 9 Nicotine has also been shown to promote the conversion of adult rat arterial VSMC from a contractile to a synthetic phenotype early in primary culture. 8 Stenoses in multifocal FMD are due to fibromuscular ridges, which may form webs across the arterial lumen.
1,2 Since tobacco constituents have been shown to influence VSMC proliferation and phenotype, perhaps smoking promotes the growth of these ridges, thus increasing the severity of the stenosis.
This study has implications for the management of FMD. Firstly, given the likely pathogenetic influence of smoking in susceptible patients with FMD, smoking cessation may play a role in prevention of progression of FMD lesions, preventing clinical disease in patients with incidentally-discovered FMD, retarding the development of clinically-significant contralateral disease in patients with unilateral clinically-significant lesions, and inhibiting ipsilateral progression.
Secondly, reports of familial occurrence suggest that there is an inherited predisposition to the development of FMD. 1, 16 Since smoking may accelerate progression of FMD, relatives of FMD patients should be strongly discouraged from smoking.
Thirdly, further elucidation of the mechanisms by which smoking contributes to the development and progression of FMD will assist in the understanding of FMD and its primary aetiology.
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